SCHEMBL21024103

SCHEMBL21024103

CCc1cc(C(F)(F)F)nn1C1CCCC1

nearest known ligand 0.42

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 2/20 0.42
NR3C2 P08235 1/20 0.40
LRRK2 Q5S007 2/20 0.36
GAA P10253 1/20 0.36
MAPK13 O15264 1/20 0.36
MAPK12 P53778 1/20 0.36
MAPK11 Q15759 1/20 0.36
MAPK14 Q16539 1/20 0.36
KCNH2 Q12809 1/20 0.35
PDE4A P27815 4/20 0.33
PDE4B Q07343 4/20 0.33
PDE4C Q08493 4/20 0.33
PDE4D Q08499 4/20 0.33
KDM4E B2RXH2 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HSD17B10 Q99714 1/20 0.33
TGFBR1 P36897 1/20 0.32
HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21023833 0.97 TRPV1 (0.40) TRPV1NR3C2LRRK2GAAMAPK13
SCHEMBL19954622 0.87 GAA (0.37) TRPV1NR3C2LRRK2GAAKCNH2
SCHEMBL2685387 0.83 NR3C2 (0.42) TRPV1NR3C2GAAMAPK13MAPK12
SCHEMBL19954551 0.82 TRPV1 (0.35) TRPV1NR3C2LRRK2GAATGFBR1
SCHEMBL19954609 0.79 TRPV1 (0.42) TRPV1NR3C2LRRK2KCNH2
SCHEMBL21024096 0.79 GAA (0.44) TRPV1NR3C2GAAMAPK13MAPK12
SCHEMBL21023570 0.78 NR3C2 (0.38) TRPV1NR3C2GAAALDH1A1
SCHEMBL21023578 0.78 MAPK13 (0.43) TRPV1NR3C2LRRK2GAAMAPK13
SCHEMBL12912163 0.78 GAA (0.43) TRPV1NR3C2GAAMAPK13MAPK12
SCHEMBL19954668 0.77 PLAT (0.36) TRPV1NR3C2LRRK2PDE4BTGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3080087-B1 N-SUBSTITUTED PYRAZOLYL GUANIDINE F1F0-ATPASE INHIBITORS AND THERAPEUTIC USES THEREOF LYCERA CORP (US) 2019-05-22 EP disclosed